OpenAI launches GPT-Rosalind, a specialized AI model designed to accelerate life sciences research and streamline fragmented laboratory workflows.

GPT-Rosalind is a new limited-access frontier reasoning model purpose-built specifically for life sciences research, named after pioneering chemist Rosalind Franklin

The model aims to address inefficiencies in drug development, a process typically taking 10-15 years and billions of dollars, by consolidating fragmented workflows across experimental design, software, and databases

OpenAI is also expanding a broader Codex plugin on GitHub to make AI development tools more accessible across platforms

The specialized model shifts AI's role from general-purpose assistant to domain-specific intelligence layer tailored for scientific research productivity